Metabolic activities of ginseng and its constituents, ginsenoside Rb1 and Rg1, by human intestinal microfora

Journal of Ginseng Research

Volumn 35, Issue 3, 2011, Pages 301-307

  Choi, Jong Ryul ^a   Hong, Sung Woon ^a   Kim, Yuri ^a   Jang, Se Eun ^a   Kim, Nam Jae ^a   Han, Myung Joo ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Intestinal microfora; Metabolism; Pharmacological effect

Indexed keywords

BACTERIA (MICROORGANISMS); PANAX GINSENG;

EID: 80053346693     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2011.35.3.301     Document Type: Article

References (24)

1. Kobashi K, Akao T. Relation of intestinal bacteria to pharmacological effect of glycosides. Biosci Microfora 1997; 16:1-7.
2. Kim DH. Intestinal microfora activate the pharmacological effects of herbal medicines. Nat Prod Sci 2002;8:35-43.
3. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol 1998;50:1155-1160.
4. Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration-measurement of compound K by enzyme immunoassay. Biol Pharm Bull 1998;21:245-249.
5. Lee J, Lee E, Kim D, Lee J, Yoo J, Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol 2009;122:143-148.
6. Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apop-tosis in tumor cells. Biochem Biophys Res Commun 1998;246:725-730.
7. Choo MK, Park EK, Han MJ, Kim DH. Antiallergic activity of ginseng and its ginsenosides. Planta Med 2003;69:518-522.
8. Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 2002;25:743-747.
9. Bae EA, Kim NY, Han MJ, Choo MK, Kim DH. Transformation of ginsenosides to compound K (IH-901) by lactic acid bacteria of human intestine. J Microbiol Bio-technol 2003;13:9-14.
10. Kobashi K, Nakata H, Takebe H, Terasawa K. Relation of intestinal microfora to Syo. Wakan-iyaku-kaishi 1984;1:166-167.
11. Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their trans-formants. Arch Pharm Res 2004;27:61-67.
12. Kim YS, Kim JJ, Cho KH, Jung WS, Moon SK, Park EK, Kim DH. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperi-din, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. J Microbiol Biotechnol 2008;18:1109-1114.
13. Lee DS, Kim YS, Ko CN, Cho KH, Bae HS, Lee KS, Kim JJ, Park EK, Kim DH. Fecal metabolic activities of herbal components to bioactive compounds. Arch Pharm Res 2002;25:165-169.
14. Yim JS, Kim YS, Moon SK, Cho KH, Bae HS, Kim JJ, Park EK, Kim DH. Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioac-tive compounds by human intestinal microflora. Biol Pharm Bull 2004;27:1580-1583.
15. Mallet AK, Rowland IR, Bearne CA, Flynn JC, Fehilly BT, Udeen YS, Farthing MJ. Effect of dietary supplements of apple pectin, wheat bran or fat on the enzyme activity of the human faecal flora. Microb Ecol Health Dis 1988;1:23-39.
16. Reddy BS, Hanson D, Mangat S, Mathews L, Sbaschnig M, Sharma C, Simi B. Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J Nutr 1980;110:1880-1887.
17. Mykkanen H, Laiho K, Salminen S. Variations in faecal bacterial enzyme activities and associations with bowel function and diet in elderly subjects. J Appl Microbiol 1998;85:37-41.
18. Ikeda N, Saito Y, Shimizu J, Ochi A, Mizutani J, Watabe J. Variations in concentrations of bacterial metabolites, enzyme activities, moisture, pH and bacterial composition between and within individuals in faeces of seven healthy adults. J Appl Bacteriol 1994;77:185-194.
19. Bae EA, Park SY, Kim DH. Constitutive beta-glucosi-dases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull 2000;23:1481-1485.
20. Rumney CJ, Rowland IR. In vivo and in vitro models of the human colonic flora. Crit Rev Food Sci Nutr 1992;31:299-331.
21. Simon GL, Gorbach SL. The human intestinal microfora. Dig Dis Sci 1986;31(9 Suppl):147S-162S.
22. Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst 1980;64:255-261.
23. Ling WH, Korpela R, Mykkänen H, Salminen S, Hannin-en O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 1994;124:18-23.
24. Kim DH. The possible role of intestinal microflora in pharmacological activities of ginseng. Int J Biomed Pharm Sci 2011; in press.